{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T03:53:52Z","timestamp":1768622032044,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,1,15]],"date-time":"2009-01-15T00:00:00Z","timestamp":1231977600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1007\/s00120-008-1901-4","type":"journal-article","created":{"date-parts":[[2009,1,13]],"date-time":"2009-01-13T17:58:32Z","timestamp":1231869512000},"page":"143-150","source":"Crossref","is-referenced-by-count":3,"title":["Metastasenchirurgie in kurativer Absicht beim Urothelkarzinom","Complete resection of urothelial cancer metastases with curative intent"],"prefix":"10.1007","volume":"48","author":[{"given":"J.","family":"Lehmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Suttmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Albers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Volkmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.E.","family":"Gschwend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Fechner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Spahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Heidenreich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Odenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Seif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"N\u00fcrnberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"W\u00fclfing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Greb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"K\u00e4lble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-O.","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.F.","family":"Fieseler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Krege","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Retz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Schulte-Baukloh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kamradt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"St\u00f6ckle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,1,15]]},"reference":[{"key":"1901_CR1","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.eururo.2007.02.052","volume":"52","author":"Abe","year":"2007","unstructured":"Abe T, Shinohara N, Harabayashi T et al (2007) Impact of multimodal treatment on survival in patients with metastatic urothelial cancer. Eur Urol 52: 1106\u20131113","journal-title":"Eur Urol"},{"key":"1901_CR2","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/0090-4295(82)90462-9","volume":"20","author":"Cowles","year":"1982","unstructured":"Cowles RS, Johnson DE, McMurtrey MJ (1982) Long-term results following thoracotomy for metastatic bladder cancer. Urology 20: 390\u2013392","journal-title":"Urology"},{"key":"1901_CR3","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0022-5347(17)35025-5","volume":"151","author":"Dimopoulos","year":"1994","unstructured":"Dimopoulos MA, Finn L, Logothetis CJ (1994) Pattern of failure and survival of patients with metastatic urothelial tumors relapsing after cis-platinum-based chemotherapy. J Urol 151: 598\u2013600","journal-title":"J Urol"},{"key":"1901_CR4","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1200\/JCO.1999.17.8.2546","volume":"17","author":"Dodd","year":"1999","unstructured":"Dodd PM, McCaffrey JA, Herr H et al (1999) Outcome of postchemotherapy surgery after treatment with methotrexate, vinblastine, doxorubicin, and cisplatin in patients with unresectable or metastatic transitional cell carcinoma. J Clin Oncol 17: 2546\u20132552","journal-title":"J Clin Oncol"},{"key":"1901_CR5","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0022-5347(05)65284-6","volume":"167","author":"Herr","year":"2002","unstructured":"Herr HW, Bochner BH, Dalbagni G et al (2002) Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167: 1295\u20131298","journal-title":"J Urol"},{"key":"1901_CR6","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0022-5347(05)66533-0","volume":"165","author":"Herr","year":"2001","unstructured":"Herr HW, Donat SM, Bajorin DF (2001) Post-chemotherapy surgery in patients with unresectable or regionally metastatic bladder cancer. J Urol 165: 811\u2013814","journal-title":"J Urol"},{"key":"1901_CR7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0022-5347(06)00510-6","volume":"176","author":"Kassouf","year":"2006","unstructured":"Kassouf W, Leibovici D, Munsell MF et al (2006) Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy. J Urol 176: 53\u201357","journal-title":"J Urol"},{"key":"1901_CR8","doi-asserted-by":"crossref","unstructured":"Lehmann J, Suttmann H, Albers P et al. (2008) Surgery for metastatic urothelial carcinoma with curative intent: the German experimence (AUO AB 30\/05). Eur Urol (Epub ahead of print)","DOI":"10.1016\/j.eururo.2008.11.039"},{"key":"1901_CR9","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1200\/JCO.1994.12.3.483","volume":"12","author":"Loehrer","year":"1994","unstructured":"Loehrer PJ Sr, Elson P, Dreicer R et al (1994) Escalated dosages of methotrexate, vinblastine, doxorubicin, and cisplatin plus recombinant human granulocyte colony-stimulating factor in advanced urothelial carcinoma: an eastern cooperative oncology group trial. J Clin Oncol 12: 483\u2013488","journal-title":"J Clin Oncol"},{"key":"1901_CR10","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1200\/JCO.1990.8.6.1050","volume":"8","author":"Logothetis","year":"1990","unstructured":"Logothetis CJ, Dexeus FH, Finn L et al (1990) A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors. J Clin Oncol 8: 1050\u20131055","journal-title":"J Clin Oncol"},{"key":"1901_CR11","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-5347(17)35398-3","volume":"150","author":"Miller","year":"1993","unstructured":"Miller RS, Freiha FS, Reese JH et al (1993) Cisplatin, methotrexate and vinblastine plus surgical restaging for patients with advanced transitional cell carcinoma of the urothelium. J Urol 150: 65\u201369","journal-title":"J Urol"},{"key":"1901_CR12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0302-2838(01)00026-4","volume":"41","author":"Oosterlinck","year":"2002","unstructured":"Oosterlinck W, Lobel B, Jakse G et al (2002) Guidelines on bladder cancer. Eur Urol 41: 105\u2013112","journal-title":"Eur Urol"},{"key":"1901_CR13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0090-4295(00)00867-0","volume":"57","author":"Otto","year":"2001","unstructured":"Otto T, Krege S, Suhr J, R\u00fcbben H (2001) Impact of surgical resection of bladder cancer metastases refractory to systemic therapy on performance score: a phase II trial. Urology 57: 55\u201359","journal-title":"Urology"},{"key":"1901_CR14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00042307-200409000-00007","volume":"14","author":"Shah","year":"2004","unstructured":"Shah JB, McKiernan JM (2004) Novel therapeutics in the treatment of bladder cancer. Curr Opin Urol 14: 287\u2013293","journal-title":"Curr Opin Urol"},{"key":"1901_CR15","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1200\/JCO.2002.20.5.1361","volume":"20","author":"Siefker-Radtke","year":"2002","unstructured":"Siefker-Radtke AO, Millikan RE, Tu SM et al (2002) Phase III trial of fluorouracil, interferon alpha-2b, and cisplatin versus methotrexate, vinblastine, doxorubicin and cisplatin in metastatic or unresectable urothelial cancer. J Clin Oncol 20: 1361\u20131367","journal-title":"J Clin Oncol"},{"key":"1901_CR16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/01.ju.0000099823.60465.e6","volume":"171","author":"Siefker-Radtke","year":"2004","unstructured":"Siefker-Radtke AO, Walsh GL, Pisters LL et al (2004) Is there a role for surgery in the management of metastatic urothelial cancer? The MD anderson experience. J Urol 171: 145\u2013148","journal-title":"J Urol"},{"key":"1901_CR17","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1200\/JCO.2001.19.3.666","volume":"19","author":"Stein","year":"2001","unstructured":"Stein JP, Lieskovsky G, Cote R et al (2001) Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 19: 666\u2013675","journal-title":"J Clin Oncol"},{"key":"1901_CR18","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1200\/JCO.2001.19.10.2638","volume":"19","author":"Sternberg","year":"2001","unstructured":"Sternberg CN, de Mulder PH, Schornagel JH et al (2001) Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European organization for research and treatment of cancer protocol no. 30924. J Clin Oncol 19: 2638\u20132646","journal-title":"J Clin Oncol"},{"key":"1901_CR19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0022-5347(17)42494-3","volume":"139","author":"Sternberg","year":"1988","unstructured":"Sternberg CN, Yagoda A, Scher HI et al (1988) M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium. J Urol 139: 461\u2013469","journal-title":"J Urol"},{"key":"1901_CR20","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1097\/01.ju.0000067601.29966.4a","volume":"169","author":"Sweeney","year":"2003","unstructured":"Sweeney P, Millikan R, Donat M et al (2003) Is there a therapeutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the bladder? J Urol 169: 2113\u20132117","journal-title":"J Urol"},{"key":"1901_CR21","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1200\/JCO.2000.18.17.3068","volume":"18","author":"von","year":"2000","unstructured":"von der Maase H, Hansen SW, Roberts JT et al (2000) Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol 18: 3068\u20133077","journal-title":"J Clin Oncol"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-008-1901-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-008-1901-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-008-1901-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T15:41:51Z","timestamp":1684856511000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-008-1901-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,15]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["1901"],"URL":"https:\/\/doi.org\/10.1007\/s00120-008-1901-4","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,15]]}}}